Mustang Bio, Inc. · NASDAQ:MBIO
Armistice Capital, LLC reported a 9.99% stake in Mustang Bio, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC reported a 9.99% stake in Mustang Bio, Inc., 5,106,287 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 5,106,287
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 9.99% | 5,106,287 |
| Steven Boyd | 9.99% | 5,106,287 |
Source
Related
- Mustang Bio, Inc.
- Armistice Capital, LLC
- Mustang Bio, Inc. shareholders
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2025
- Form 4 · Litchman Manuel MD · Apr 27, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Jan 5, 2026
- Schedule 13D/A · Fortress Biotech, Inc. · Oct 1, 2025
- Schedule 13G/A · Mitchell P. Kopin · Aug 12, 2025
- Schedule 13G/A · Mitchell P. Kopin · May 9, 2025